Is prophylactic therapeutics efficient against anaphylactoid reactions during anaesthesia?;La prévention du risque allergique peut-elle être assurée par une médication préanesthésique?

Annales Francaises d'Anesthesie et de Reanimation

Volumn 21, Issue SUPPL. 1, 2002, Pages 151-167

  Dewachter, P ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALIMEMAZINE TARTRATE; ANESTHETIC AGENT; APHILAN; BROMPHENIRAMINE; BUCLIZINE; CARBINOXAMINE; CETIRIZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIMETIDINE; CYPROHEPTADINE; DEXCHLORPHENIRAMINE MALEATE; DEXTRAN; DOXYLAMINE; FAMOTIDINE; FEXOFENADINE; GLUCOCORTICOID; HYDROXYZINE; LORATADINE; MEPYRAMINE; MEQUITAZINE; MISTALINE; MIZOLASTINE; NIZATIDINE; OXATOMIDE; PEPCIDDUO; PROMETHAZINE; PROPOFOL; QUITADRILL; RANITIDINE; SEROTONIN ANTAGONIST; TERFENADINE; ULCINE;

ALLERGY; ANAPHYLAXIS; ANESTHESIA; DRUG EFFECT; DRUG EFFICACY; HISTAMINE RELEASE; HUMAN; PRIMARY PREVENTION; REVIEW; SECONDARY PREVENTION;

EID: 0036275398     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0750-7658(01)00566-4     Document Type: Article

References (130)

1. Premedication
2. Epidémiologie des réactions anaphylactoïdes peranesthésiques. Quatrième enquête multicentrique (Juillet 1994-décembre 1996)
3. The role of histamine in adverse reactions to intravenous agents
4. 2 histamine receptor antagonists on cardiovascular and pulmonary responses
5. Effects of infused histamine: Correlation of plasma histamine levels and symptoms
6. Cardiovascular effects of histamine infusion in man
7. 2 receptor antagonists on anaphylaxis in the guinea-pig
8. 2 receptor antagonists: Synopsis of three randomized controlled trials
9. The role of histamine in the physiologic alterations of IgE anaphylaxis in the rabbit
10. Airway constriction following atracurium is due to histamine release abstract
11. Les récepteurs H2 ne semblent pas impliqués dans le bronchospasme à l'histamine chez le lapin résumé
12. H1 + H2 receptor antagonists for premedication in anaesthesia and surgery: A critical view based on randomized clinical trials with Haemaccel and various antiallergic drugs
13. The use of H1 and H2 histamine antagonists, with morphine anesthesia: A double-blind study
14. 2-receptor antagonists: Indications, benefits and possible problems
15. 2-receptor antagonists
16. 1 antagonist on airway dynamics and responsiveness to inhaled histamine in mild asthma
17. Prophylactic administration of H1 and H2 receptor blockers in the prevention of protamine related haemodynamic effects
18. Incidence and clinical importance of perioperative histamine release randomised study of volume loading and antihistamines after induction of anaesthesia
19. Effects of oral antihistamine premedication on mivacurium-induced histamine release and side effects
20. 1-receptor antagonists
21. Torsades de pointes after astemizole overdose
22. Prolonged Q-T interval following astemizole overdose
23. Cardiotoxic effects of astemizole overdose in children
24. Torsades de pointes ventricular tachycardia associated with astemizole overdose
25. Giant U waves and associated ventricular tachycardia complicating astemizole overdose: Successful therapy with intravenous magnesium
26. Torsades de pointes complicating treatment with terfenadine
27. Astemizole-induced torsades de pointes letter
28. Torsades de pointes occurring in association with terfenadine use
29. Torsades de pointes complicating treatment with terfenadine
30. Cardiotoxic effect with convulsions in terfenadine overdose
31. Hydroxyzine hydrochloride: Possible adverse cardiac interactions
32. 2 receptor antagonists on cardiovascular function during systemic anaphylaxis in guinea pigs
33. Xllles Journées de l'Association française des centres régionaux de pharmacovigilance
34. Substances responsables des chocs anaphylactoïdes peranesthésiques. Troisième enquête multicentrique française (1991-1994)
35. Histamine and 5-hydroxytryptamine (serotonin) and their antagonists
36. Effects of infused histamine on asthmatic and normal subjects: Comparison of skin test responses
37. Inhibitory effect of hydroxyzine on antigen-induced histamine release in vivo
38. Comparison of the suppressive effect of astemizole, terfenadine, and hydroxyzine on histamine-induced wheals and flares in humans
39. Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-aceter release and eosinophil recruitment in human skin
40. IgE spécifiques et histaminolibération
41. 2 et de tritoqualine
42. Effets antihistaminiques des psychotropes
43. The epidemiology and clinical features of anaphylacfic reactions in anaesthesia
44. Anaphylactoid reaction to chymopapain
45. Chocs anaphylactiques après levée de garrot en chirurgie orthopédique
46. Bacitracin irrigation: A cause of anaphylaxis in the operating room
47. An anaphylactic reaction to topical fibrin glue
48. Prevalence of anaphylactic reactions to aprotinin: Analysis of two hundred forty-eight reexposures to aprotinin in heart operations
49. Case report: Recurrent anaphylactic shock to radiographic contrast media. Evidence supporting an exceptional IgE-mediated reaction
50. Prophylaxis against repeated radiocontrast media in 857 cases
51. Adverse reactions to radiocon trast media in an Indian population
52. Allergy and contrast media
53. Réactions sévères avec les produits de contraste iodés: L'anaphylaxie est-elle responsable?
54. Breakthrough adverse reactions to low-osmolar contrast media after steroid premedication
55. Anaphylactoid reaction to ranitidine in labour
56. Anaphylactoid reaction to ranitidine in an obstetric patient
57. Anaphylactoid reaction to ranitidine in an obstetric patient
58. Side effects, structure and H2-receptor antagonists letter
59. Anaphylactic reaction to ranitidine
60. Nizatidine anaphylaxis
61. Urticaria from ranitidine
62. The role of histamine in cardiac anaphylaxis; characterization of histaminergic H1 and H2 receptor effects
63. Acceleration of idioventricular rhythms by histamine in guinea pig hearts
64. The hemodynamic effects of intravenous cimetidine in intensive care unit patients: A double-blind, prospective study
65. Bolus injection of cimetidine and hypotension in patients in the intensive care unit. Incidence and mechanisms
66. Haemodynamic effects of the i.v. administration of cimeddine or ranitidine in the critically ill patient. A double-blind prospective study
67. The hemodynamic effects of intravenous cimetidine versus ranitidine in intensive care unit patients: A double-blind prospective cross-over study
68. Haemodynamic effects of famotidine and cimetidine in critically ill patients
69. Life-threatening arrhythmias and intravenous cimetidine
70. Sinus arrest associated with cimetidine
71. The role of histamine in the cardiovascular system
72. Inhibition of histamine release by histamine controlled by H2 receptor
73. Role of H2-receptor antagonists in the feedback of histamine
74. Histamine suppression of in vivo eosinophil accumulation and histamine release in human allergic reactions
75. Cardiac arrest after intravenous injection of cimetidine
76. Release of histamine by H2 receptor antagonists
77. Are hypotension and rash after atracurium really caused by histamine release?
78. 2 antagonists reduced mortality in chymopapain anaphylaxis
79. Comparison of three pretreatment protocols to prevent anaphylactoid reactions to radiocontrast media
80. Antihistamine prophylaxis and general anaesthesia
81. Incidence and severity of anaphylactoid reactions to colloid volume substitutes
82. Choc anaphylactique gravissime après induction anesthésique
83. Latex hypersensitivity reactions despite prophylaxis
84. Latex allergy: Failure of prophylaxis to prevent severe reaction
85. Allergic reaction to latex from stopper of a medication vial
86. Latex anaphylaxis causing heart block: Role of ranitidine
87. Probable grade IV dextran-induced anaphylactic reaction despite hapten inhibition
88. Severe anaphylactic reaction to aprotinin
89. Le risque allergique de l'aprotinine
90. Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material
91. Hapten inhibition of passive antidextran anaphylaxis in guinea pigs. Role of molecular size in anaphylactogenicity and precipitability of dextran fractions
92. Susbtituts colloïdaux du plasma
93. Safety of dextran in relation to other colloids. Ten years experience with hapten inhibition
94. Prevention of dextran anaphylaxis. Ten years experience with hapten dextran
95. Serious complications with dextran-70 despite hapten prophylaxis
96. Anaphylaxis during anaesthesia. Results of a two-year survey in France
97. Substituted ammonium ions as allergenic determinants in drug allergy
98. Drug allergenic determinants
99. Anaphylactic reactions to suxamethonium: Prevention of mediator release by choline
100. Rapid pre-operative immunotherapy in a patient allergic to muscle relaxants
101. Preventing muscle relaxants anaphylaxis with monovalent haptens. A preliminary study
102. Prevention by monovalent haptens of IgE-dependant leucocyte histamine release to muscle relaxants
103. Utilisation d'un haptène monovalent injectable type citicholine dans l'inhibifion de la réactivité cutanée allergique aux myorelaxants. A propos de deux cas
104. Histamine release and atracurium
105. The cardiovascular effects of mivacurium chloride (BW B 1090U) in patients receiving nitrous oxide-opiatebarbiturate anesthesia
106. Modulation of histamine release by neuromuscular blocking drugs
107. Muscle relaxants and histamine release
108. Anaphylaxis during anaesthesia: Currents aspects of diagnosis and prevention
109. Latex allergy in spina bifida patients-prevention by primary prophylaxis
110. Task force on allergic reaction to latex. American academy of allergy and immunology. Committee report
111. Allergic reactions occurring during anaesthesia. Review
112. Retention of airborne latex particles by a bacterial and viral filter used in anaesthesia
113. Non specific interactions in anti-agent IgE-RIA to anesthetic agents
114. Pathogenesis of allergic reactions to anaesthetic drugs
115. Life-threatening anaphylactoid reactions to propofol (Diprivan)
116. Non-specific cross-reactivity of hydrophobic serum IgE to hydrophobic drugs
117. Aprotinin in staged heart transplantation: Anaphylactic potential of repeated exposure
118. Strong cross-reaction to human anti-aprotinin antibodies from heart transplant patient with (Ar [15]) aprotinin
119. Choc anaphylactique après dose-test d'aprotinine en chirurgie orthopédique pédiatrique
120. Réaction anaphylactique à l'aprotinine: Intérêt diagnostique des tests intradermiques
121. Anaphylaxis during general anaesthesia. Prevention and management
122. Mast cell tryptase in anaesthetic anaphylactoid reactions
123. Recommandations pour la pratique de l'antibioprophylaxie en chirurgie. Actualisation 1999
124. Allergy and anaesthesia
125. Lung biology in health and disease: The mast cell in health and disease
126. The use of epinephrine in the treatment of anaphylaxis
127. Allergic reactions during anaesthesia
128. Clinical management of latex-allergic children
129. Anaesthesia for the allergic patient